HAWTHORNE, N.Y. --(BUSINESS WIRE)--Feb. 9, 2017-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and nine months ended December 31, 2016 . Quarter ended December 31, 2016 Highlights - compared to December 31, 2015
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Feb. 7, 2018-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and nine months ended December 31, 2017 . Quarter ended December 31, 2017 Highlights ─ compared to December 31, 2016
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Feb. 3, 2020-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and nine months ended December 31, 2019 . Quarter ended December 31, 2019 Highlights ─ compared to December 31, 2018
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jan. 27, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine months ended December 31, 2020 . Quarter ended December 31, 2020 Highlights ─ compared to December 31,
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jan. 27, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine months ended December 31, 2021 . Quarter ended December 31, 2021 Highlights ─ compared to December 31,
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jan. 24, 2023-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine months ended December 31, 2022 . Quarter ended December 31, 2022 * Highlights ─ compared to December 31,
Alerts are e-mailed to you whenever certain new company information is posted to this site.